1
|
Bogale AL, Teklehaymanot T, Ali JH, Kassie GM, Medhin G. The Recurrence of Cervical Precancerous Lesion Among HIV Positive and Negative Ethiopian Women After Cryotherapy: A Retrospective Cohort Study. Cancer Control 2022; 29:10732748221129708. [PMID: 36151596 PMCID: PMC9513568 DOI: 10.1177/10732748221129708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Background Early testing and treatment is among the successful strategies for the
prevention and control of cervical precancerous and invasive cancer, and a
paramount for women with HIV. In Ethiopia, visual inspection with acetic
acid for screening and cryotherapy treatment is commonly practiced, though
the recurrence of the precancerous lesion after treatment has not been well
documented. Objective This study was aimed to estimate the association of HIV status and the
recurrence of cervical precancerous lesion after cryotherapy among Ethiopian
women. Methods We conducted a retrospective cohort study from January to April 2021. The
time to the incidence of recurrence was compared between HIV positive and
HIV negative women. Cox regression models were used to adjust the analyses
for potential confounders, and only women treated with cryotherapy after a
positive Visual Inspection with Acetic acid (VIA) screening test were
included. Results A total of 140 eligible patient cards were included in the analysis with the
median follow-up of 15.5 months. The overall recurrence rate was 15.7%
(22/140), with a greater proportion among HIV negative women, 19.0% (4/21)
than HIV positive 15.1% (18/119). Prolonged use of corticosteroid and higher
age were the major significant predictors of a higher likelihood of
recurrence. The recurrence of screening positive lesion was higher among
women aged above 39 years (hazard ratio (HR) of 11.94 (95% CI, 1.07-133.04;
P = .04), and women with prolonged use of corticosteroid (HR = 7.82, 95% CI
= 1.04-58.75; P = .046) than their counterparts. Conclusion The recurrence of cervical precancerous lesion after cryotherapy was higher
than the expert panel report by WHO with a higher proportion among women of
old age and prolonged corticosteroid use. Cryotherapy showed a satisfying
performance against the recurrence of cervical disease diagnosed through
VIA. To substantiate, our findings, further prospective cohort study is also
recommended.
Collapse
Affiliation(s)
- Agajie Likie Bogale
- Aklilu Lemma Institute of Pathobiology, 128164Ethiopian Public Health Institute, Ethiopia.,Program of Tropical and Infectious Diseases, 37602Addis Ababa University, Ethiopia
| | | | | | | | - Girmay Medhin
- Program of Tropical and Infectious Diseases, 37602Addis Ababa University, Ethiopia
| |
Collapse
|
2
|
Zanini LAG, Reis RJ, Laporte GA, Vieira SC, Zanella JDF, Machado GM. Analysis of the surgical management of patients with recurrent cervical cancer after radiotherapy and chemotherapy. Rev Col Bras Cir 2020; 47:e20202443. [PMID: 32555966 DOI: 10.1590/0100-6991e-20202443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2019] [Accepted: 03/02/2020] [Indexed: 12/24/2022] Open
Abstract
OBJECTIVE To analyze the results of morbidity and survival after curative and palliative surgery in recurrent cervical cancer patients who underwent chemoradiation as their primary treatment. Another goal was to assess the factors associated with curative and non-curative procedures. METHODS This was a retrospective cohort consisting of patients undergoing surgery curative and palliative from January 2011 to December 2017 at a high complexity oncology center. Outcome of morbidity was reported according to the Clavien-Dindo classification, and survival analysis was carried out using the Kaplan-Meir method. To assess the factors associated with the procedures, a univariate analysis using the Mann-Whitney U test was performed. RESULTS Two radical hysterectomies, three pelvic exenterations with curative intent, and five palliatives pelvic exenterations were performed. In the curative group, there were major complications in 40% of the cases, and the median survival time was 16 months. In the palliative group, there were major complications in 60% of the cases, and the median survival time was 5 months. Advanced staging (p-value= 0.02), symptoms (p-value=0.04), tumor size greater than five centimeters (p-value=0.04), and more than three organs involved (p-value=0.003) were factors significantly associated with non-curative surgery. CONCLUSIONS The morbidity rates of this study were higher in palliative group, and the median survival time was lower in the palliative group than the curative group, but this difference in survival was not statistically significant. Advanced stage, symptoms, tumor size and number of organs involved are factors that should be taken into consideration when indicating surgical salvage.
Collapse
Affiliation(s)
| | - Rosilene Jara Reis
- Santa Casa de Misericórdia of Porto Alegre, Cirurgia oncológica - Porto Alegre - RS - Brasil
| | | | | | - Janice de Fátima Zanella
- Universidade de Cruz Alta, Programa de Pós Graduação em Atenção Integral à Saúde - Cruz Alta - RS - Brasil
| | | |
Collapse
|
3
|
Zhang Y, Zhang X, Zhu H, Liu Y, Cao J, Li D, Ding B, Yan W, Jin H, Wang S. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer. Cancer Manag Res 2020; 12:719-730. [PMID: 32099468 PMCID: PMC7002755 DOI: 10.2147/cmar.s231796] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2019] [Accepted: 12/19/2019] [Indexed: 12/19/2022] Open
Abstract
Background Cervical cancer (CC) is one of the most common malignant tumors in women, and its treatment is often accompanied by high recurrence. We aimed to identify the long non-coding RNAs (lncRNAs) associated with CC recurrence. Methods We downloaded lncRNAs expression data of CC patients from The Cancer Genome Atlas (TCGA) dataset and used Cox regression models to analyze the lncRNAs relationship with CC recurrence. The significantly associated lncRNAs were utilized to construct a recurrence risk score (RRS) model. Bioinformatics analyses were used to assess the potential role of the critical lncRNAs in CC recurrence. The effect of critical lncRNAs on CC phenotype was determined by in vitro experiments. Results Using Cox regression analysis, four lncRNAs, ie, HCG11, CASC15, LINC00189, and LINC00905, were markedly associated with worse recurrence-free survival (RFS) of CC, whereas three lncRNAs, including HULC, LINC00173, and MIR22HG, were the opposite. After constructing the RRS model, Kaplan-Meier analysis revealed that patients with high RRS had significantly increased risk of recurrence. Among the 20 types of tumors in the TCGA database which all had adjacent normal tissues, MIR22HG and HCG11were significantly downregulated in 18 and 10 types of tumors including CC, respectively. Increased MIR22HG was significantly relevant to decreased risks of recurrence among the subgroups of age at diagnosis < 45 (Hazard Ratio (HR) = 0.26), stage I/II (HR = 0.33), T stage I/II (HR = 0.30), chemotherapy (HR = 0.18), and molecular therapy (HR = 0.16). Functionally, elevated MIR22HG expression could suppress CC cell proliferation, migration and invasion. Conclusion MIR22HG has a fundamental role in CC recurrence and could be served as a potential prognostic biomarker.
Collapse
Affiliation(s)
- Yan Zhang
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, People's Republic of China
| | - Xing Zhang
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, People's Republic of China
| | - Haixia Zhu
- Clinical Laboratory, Affiliated Tumor Hospital of Nantong University (Nantong Tumor Hospital), Nantong, People's Republic of China
| | - Yang Liu
- Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People's Republic of China
| | - Jian Cao
- Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People's Republic of China
| | - Dake Li
- Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People's Republic of China
| | - Bo Ding
- Department of Gynecology and Obstetrics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Wenjing Yan
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, People's Republic of China
| | - Hua Jin
- Clinical Laboratory, Affiliated Tumor Hospital of Nantong University (Nantong Tumor Hospital), Nantong, People's Republic of China
| | - Shizhi Wang
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, People's Republic of China
| |
Collapse
|